Valeria Pereira de Sousa

Instituição:

Universidade Federal do Rio de Janeiro

Centro:

Centro de Ciências da Saúde

Unidade:

Faculdade de Farmácia

Departamento:

Departamento de Fármacos e Medicamentos

ORCID:

não disponível no Lattes


Formação:
  • Trinity College Dublin - School of Pharmacy and Pharmaceutical Sciences

    | Pós-Doutorado | 2010 - 2010
  • Universidade Federal do Rio de Janeiro

    Química Biológica | Doutorado | 1998 - 2002
  • Universidade Federal do Rio de Janeiro

    Química Biológica | Mestrado | 1997 - 1998
  • Universidade Federal do Rio de Janeiro

    Farmácia Industrial | Graduação | 1993 - 1996
Laboratórios:
Nuvens de Palavras:
Artigos:

(94.31% artigos com DOI)

Titulo DOI Ano
Evaluation of Silybin Nanoparticles against Liver Damage in Murine Schistosomiasis mansoni Infection 10.3390/pharmaceutics16050618 2024
Identification and Characterization of Rotigotine Degradation Products by HPLC Coupled DAD and CAD Detectors and HRMS Through Q-Orbitrap and Electrospray Ionization 10.1016/j.xphs.2024.05.028 2024
Development of formulation containing caffeine for Dermal Delivery 10.1111/ics.12841 2023
Use of In silico Methodologies to Predict the Bioavailability of OralSuspensions: A Regulatory Approach 10.2174/0113816128257028231030113156 2023
Development of Novel Montmorillonite-Based Sustained Release System for Oral Bromopride Delivery. 10.1016/j.ejps.2022.106222 2022
Preparation and evaluation of red propolis and nystatin cyclodextrin inclusion complexes against oral microbiome opportunistic microorganisms 10.1590/fst.118022 2022
Alternative Methods for Pulmonary-Administered Drugs Metabolism: a Breath of Change 10.2174/1389557522666220620125623 2022
Application of in silico methods in clinical research and development of drugs and their formulation, a scoping review (Pub Med Central). 10.1079/searchRxiv.2022.00006 2022
Copaiba Oil Resin Exerts an Additive Effect to Babassu Oil on Behavioral Changes in Human Endometriotic Cell Cultures 10.3390/ph15111414 2022
Macitentan: An overview of its degradation products, process-related impurities, and in silico toxicity 10.1016/j.comtox.2022.100255 2022
Development of a validation protocol method for nucleic acid testing to detect human immunodeficiency virus, hepatitis C virus, and hepatitis B virus 10.1590/0001-3765202220211321 2022
Application of in silico methods in clinical research and development of drugs and their formulation: A scoping review 10.7324/japs.2023.87792 2022
Development and validation of a fast HPLC method for methyldopa enantiomers using superficially porous particle based macrocyclic glycopeptide stationary phase 10.1016/j.microc.2021.105957 2021
Evaluation of dermorphin metabolism using zebrafish water tank model and human liver microsomes 10.2174/1389200222666210216095753 2021
Development of transdermal based hydrogel formulations of vinorelbine with an evaluation of their in vitro profiles and activity against melanoma cells and in silico prediction of drug absorption 10.1016/j.jddst.2021.102449 2021
Stability Indicating Methods for Determination of Third Generation Antiepileptic Drugs and Their Related Substances 10.1080/10408347.2021.1890544 2021
Clofazimine functionalized polymeric nanoparticles for brain delivery in the tuberculosis treatment 10.1016/j.ijpharm.2021.120655 2021
Benign prostatic hyperplasia therapy through liquisolid technology composed of polymer-layered nanocomposites based on silicate that contain babassu oil and copaiba oil-resin 10.1016/j.jddst.2021.102586 2021
Lopinavir/Ritonavir: A Review of Analytical Methodologies for the Drug Substances, Pharmaceutical Formulations and Biological Matrices 10.1080/10408347.2021.1920364 2021
Development of rivaroxaban microemulsion-based hydrogel for transdermal treatment and prevention of venous thromboembolism 10.1016/j.colsurfb.2021.111978 2021
Forced Degradation Studies of Norepinephrine and Epinephrine from dental anesthetics: Development of Stability-Indicating HPLC Method and In Silico Toxicity evaluation 10.1002/bmc.4832 2020
Full-factorial design for statistical planning of attritor milling parameters and evaluation of effects on particle size and structure of sodium-montmorillonite 10.1088/2631-8695/ab7d85 2020
Post-marketing assessment of generic tamoxifen in Brazilian breast cancer patients 10.1111/bcpt.13368 2020
Development of inhaled formulation of modified clofazimine as an alternative to treatment of tuberculosis 10.1016/j.jddst.2020.101805 R 2020
Vancomycin-loaded nanoparticles against vancomycin intermediate and methicillin resistant Staphylococcus aureus strains 10.1088/1361-6528/ab97d7 2020
A high throughput approach for determination of dermorphin in human urine using LC-HRMS and LC-MS/MS for doping control purposes 10.1002/jms.4593 2020
In Silico studies of novel Sildenafil self-emulsifying drug delivery system absorption improvement for pulmonary arterial hypertension 10.1590/0001-3765202020191445 2020
Effects of a novel roflumilast and formoterol fumarate dry powder inhaler formulation in experimental allergic asthma 10.1016/j.ijpharm.2020.119771 2020
In Vitro-In Vivo Correlation for Desvenlafaxine Succinate Monohydrate Extended Release Tablets 10.1208/s12249-020-01740-x 2020
Nanoparticles Loaded with a New Thiourea Derivative: Development and In Vitro Evaluation Against Leishmania Amazonensis 10.2174/1567201817666200704132348 2020
Tobramycin: A review of detectors used in analytical approaches for drug substance, its impurities and in pharmaceutical formulation 10.1016/j.microc.2020.105658 2020
Rotigotine: A Review of Analytical Methods for the Raw Material, Pharmaceutical Formulations and Its Impurities 10.1093/jaoacint/qsaa145 2020
Screening method of mildronate and over 300 doping agents by reversed-phase liquid chromatography-high resolution mass spectrometry 10.1016/j.jpba.2020.113870 2020
Characterization and in vitro antitumor activity of polymeric nanoparticles loaded with Uncaria tomentosa extract 10.1590/0001-3765202020190336 2020
Ezetimibe: A Review of Analytical Methods for the Drug Substance, Pharmaceutical Formulations and Biological Matrices 10.1080/10408347.2020.1857222 2020
Development of USP Apparatus 3 Dissolution Method with IVIVC for Extended Release Tablets of Metformin Hydrochloride and Development of a Generic Formulation 10.1248/cpb.c18-00579 2019
Development and validation of a quantification method for alpha-humulene and trans-caryophyllene in Cordia Verbenacea by high performance liquid chromatography 10.1016/j.bjp.2019.01.009 2019
Evaluation of the Effectiveness of the Notification Process in the Area of Health Products 10.1016/j.hlpt.2019.03.005 2019
Development of a liquid chromatography Q Exactive high resolution mass spectrometry method by the Box-Behnken design for the investigation of sibutramine urinary metabolites 10.1016/j.jchromb.2019.121726 2019
Evaluation of the in vitro release and permeation of Cordia verbenacea DC essential oil from topical dosage forms 10.1016/j.jddst.2019.101173 2019
A promising oral fucoidan-based antithrombotic nanosystem: Development, activity and safety 10.1088/1361-6528/aaae5b 2018
Development and validation of a RP-HPLC method for Roflumilast and its degradation products 10.1080/10826076.2018.1436067 2018
Development of a Dissolution Method for Gliclazide Modified-Release Tablets Using USP Apparatus 3 with in Vitro-in Vivo Correlation 10.1248/cpb.c17-00933 2018
Development and validation of a stability-indicating HPLC method for topiramate using mixed-mode column and charged aerosol detector 10.1002/jssc.201701340 2018
Development and Characterization of Dapsone Cocrystal Prepared by Scalable Production Methods 10.1208/s12249-018-1101-5 2018
Zebrafish ( Danio rerio ): A valuable tool for predicting the metabolism of xenobiotics in humans? 10.1016/j.cbpc.2018.06.005 2018
A synergistic nanoformulation of babassu and copaiba oils as natural alternative for prevention of benign prostatic hyperplasia 10.1016/j.jddst.2018.07.013 2018
Physicochemical quality profiles of commercial oral tablets and capsules containing lutein - impact of insufficient specific sanitary regulations 10.1590/0001-3765201820170972 2018
Blueberry Residue Encapsulation by Ionotropic Gelation 10.1007/s11130-018-0685-y 2018
Development of a new formulation of roflumilast for pulmonary drug delivery to treat inflammatory lung conditions 10.1016/j.ijpharm.2018.08.035 2018
Zebrafish ( Danio rerio ) Water Tank Model for the Investigation of Drug Metabolism: Progress, Outlook, and Challenges 10.1002/dta.2523 2018
Sensitive detection of topiramate degradation products by HPLC-ESI-MS using ion-pairing reagents and polarity switching 10.1002/rcm.8321 2018
Development of a Discriminative In Vitro Release Test for Rivastigmine Transdermal Patches Using Pharmacopeial Apparatuses: USP 5 and USP 6 10.1208/s12249-017-0738-9 2017
Development and characterization of poly(lactic-co-glycolic) acid nanoparticles loaded with copaiba oleoresin 10.1080/10837450.2017.1290107 2017
Identification, characterization and in silico ADMET prediction of Roflumilast degradation products 10.1016/j.jpba.2017.02.012 2017
PAMAM dendrimer hydrogel film-biocompatible material to an efficient dermal delivery of drugs 10.1007/s11051-017-3965-9 2017
Development and characterization of clay-polymer nanocomposite membranes containing sodium alendronate with osteogenic activity 10.1016/j.clay.2017.06.033 2017
Antileishmanial Thioureas: Synthesis, Biological Activity and in Silico Evaluations of New Promising Derivatives 10.1248/cpb.c17-00293 2017
Effect of the inclusion nanocomplex formed of titanium tetrafluoride and β-Cyclodextrin on enamel remineralization 10.4103/jpbs.JPBS_161_16 2017
Is zebrafish ( Danio rerio ) a tool for human-like metabolism study? 10.1002/dta.2318 2017
Development of a novel dry powder inhalation formulation for the delivery of rivastigmine hydrogen tartrate 10.1016/j.ijpharm.2016.01.066 2016
Development and Characterization of Nisin Nanoparticles as Potential Alternative for the Recurrent Vaginal Candidiasis Treatment 10.1208/s12249-016-0477-3 2016
Development and pharmacological evaluation of in vitro nanocarriers composed of lamellar silicates containing copaiba oil-resin for treatment of endometriosis 10.1016/j.msec.2016.03.094 2016
Development and validation of a dissolution test for lutein tablets and evaluation of intestinal permeability 10.1016/j.foodchem.2016.04.081 2016
Comparative evaluation of rivastigmine permeation from a transdermal system in the Franz cell using synthetic membranes and pig ear skin with in vivo-in vitro correlation 10.1016/j.ijpharm.2016.08.052 2016
Are Pediatric Antibiotic Formulations Potentials Risk Factors for Dental Caries and Dental Erosion? 10.2174/1874210601610010420 2016
Development of a Dissolution Test for Extended-Release Bromopride Pellets with In Vivo-In Vitro Correlation 10.14227/dt220215p24 2015
Design of experiments for the development of poly(d,l-lactide-co-glycolide) nanoparticles loaded with Uncaria tomentosa 10.1007/s11051-015-2883-y 2015
Topiramate: A review of analytical approaches for biological matrices 10.1002/bmc.3466 2015
Sodium Montmorillonite/Amine-Containing Drugs Complexes: New Insights on Intercalated Drugs Arrangement into Layered Carrier Material 10.1371/journal.pone.0121110 2015
Synthesis and Antiplatelet Activity of Antithrombotic Thiourea Compounds: Biological and Structure-Activity Relationship Studies 10.3390/molecules20047174 2015
Topiramate: A Review of Analytical Approaches for the Drug Substance, Its Impurities and Pharmaceutical Formulations 10.1093/chromsci/bmv120 2015
Rivastigmine hydrogen tartrate polymorphs: solid-state characterisation of transition and polymorphic conversion via milling 10.1016/j.solidstatesciences.2015.09.004 2015
The oil-resin of the tropical rainforest tree C opaifera langsdorffii reduces cell viability, changes cell morphology and induces cell death in human endometriotic stromal cultures 10.1111/jphp.12479 2015
Preparation and Evaluation of Chitosan Submicroparticles Containing Pilocarpine for Glaucoma Therapy 10.2174/1567201812666150901113240 2015
Assessment of analytical techniques for characterization of crystalline clopidogrel forms in patent applications 10.1590/S1984-82502014000200001 2014
Preparation and Characterization of Polymer/Layered Silicate Pharmaceutical Nanobiomaterials using High Clay Load Exfoliation Processes 10.1016/j.jiec.2013.12.110 2014
Crystalline forms of nonprotein drugs filed in Brazil from 1995-2005 10.4155/ppa.14.5 2014
Preparation and scale up of extended-release tablets of bromopride 10.1590/S1984-82502014000200008 2014
Development of a Discriminative Intrinsic Dissolution Method for Efavirenz 10.14227/dt210214p31 2014
Therapeutic Nanosystems for Oral Administration of Insulin 10.2174/1389201015666140915150826 2014
Development of New Babassu Oil Lipidic Nanostructured Systems; Potential Alternative for Benign Prostatic Hyperplasia Therapy 10.2174/1573413710666140806005930 2014
Segregated Delivery of Rifampicin and Isoniazid from Fixed Dose Combination Bilayer Tablets for the Treatment of Tuberculosis 2014
Poly ε-caprolactonenanoparticles loaded with Uncaria tomentosa extract: preparation, characterization, and optimization using the Box?Behnken design 10.2147/IJN.S38491 2013
Nanoemulsion containing dapsone for topical administration: a study of in vitro release and epidermal permeation 10.2147/IJN.S39383 2013
Development and Validation of a Discriminative Dissolution Test for Betamethasone Sodium Phosphate and Betamethasone Dipropionate Intramuscular Injectable Suspension 10.1208/s12249-012-9920-2 2013
Layered double hydroxides intercalated with anionic surfactants/benzophenone as potential materials for sunscreens 10.1016/j.jcis.2013.01.059 2013
Development of a doxazosin and finasteride transdermal system for combination therapy of benign prostatic hyperplasia 10.1002/jps.23715 2013
Pea Protein Provides a Promising Matrix for Microencapsulating Iron 10.1007/s11130-013-0383-8 2013
In Vitro-In Vivo Correlation of Efavirenz Tablets Using GastroPlus® 10.1208/s12249-013-0016-4 2013
Nanostructured systems containing babassu (Orbignya speciosa) oil as a potential alternative therapy for benign prostatic hyperplasia 10.2147/ijn.s47731 2013
Development of a high performance liquid chromatography method for quantification of isomers β-caryophyllene and α-humulene in copaiba oleoresin using the Box-Behnken Design 10.1016/j.jchromb.2013.09.024 2013
Characterization of a new TiF4 and β-cyclodextrin inclusion complex and its in vitro evaluation on inhibiting enamel demineralization 10.1016/j.archoralbio.2012.11.001 2013
Desenvolvimento e validação de método analítico por CLAE para a quantificação simultânea de dipropionato de betametasona e fosfato sódico de betametasona em suspensão injetável 10.1590/S0100-40422012000300027 2012
Influence of the relative composition of trace elements and vitamins in physicochemical stability of total parenteral nutrition formulations for neonatal use 10.1186/1475-2891-11-26 2012
Rational use of antioxidants in solid oral pharmaceutical preparations 10.1590/S1984-82502012000300007 2012
Development and in silico bioavailability studies of dapsone oral nanoemulsion systems 10.2147/IJN.S36479 2012
Influence of the Efavirenz Micronization on Tableting and Dissolution 10.3390/pharmaceutics4030430 2012
Preparation and Evaluation of a New Nano Pharmaceutical Excipients and drug Delivery System Based in Polyvinylpyrrolidone and Silicates 2011
Redox state of Troponin C Cysteine in the D/E helix alters the C-domain affinity for the thin filament of vertebrate striated muscle 10.1016/j.bbagen.2010.11.008 2011
Effects of a nanocomposite containing Orbignya speciosa lipophilic extract on Benign Prostatic Hyperplasia 10.1016/j.jep.2011.03.003 2011
Chemical stability study of vitamins thiamine, riboflavin, pyridoxine and ascorbic acid in parenteral nutrition for neonatal use 10.1186/1475-2891-10-47 2011
The study of vancomycin use and its adverse reactions associated to patients of a brazilian university hospital 10.1186/1756-0500-4-236 2011
Preparation and evaluation of antimicrobial activity of nanosystems for the control of oral pathogens Streptococcus mutans and Candida albican 10.2147/IJN.S25667 2011
In Vitro Characterization of Chitosan Gels for Buccal Delivery of Celecoxib: Influence of a Penetration Enhancer 10.1208/s12249-011-9725-8 2011
Preparation and evaluation of lidocaine hydrochloride in cyclodextrin inclusion complexes for development of stable gel in association with chlorhexidine gluconate for urogenital use 10.2147/IJN.S20409 2011
A Novel Transdermal Delivery System for the Anti-Inflammatory Lumiracoxib: Influence of Oleic Acid on In Vitro Percutaneous Absorption and In Vivo Potential Cutaneous Irritation 10.1208/s12249-010-9420-1 2010
Development of methodologies for dimethylaminoethanol glicolate assay in association with sunscreens in dermocosmetic formulation 101590S1984-82502010000400012 2010
Influence of oleic acid on the rheology and in vitro release of lumiracoxib from poloxamer gels 2010
Oral sustained release nystatin tablets for the treatment of oral candidiasis: formulation development and validation of UV spectrophotometric analytical methodology for content determination 10.3109/03639040903384729 2010
Are pediatric medicines risk factors for dental caries and dental erosion ? 10.1922/CDH_2406Maia06 2009
Extração e purificação de fármacos anti-inflamatórios não esteroidais ciclo-oxigenase-2 seletivos 10.1590/S0100-40422009000500040 2009
Influence of the calcium concentration in the presence of organic phosphorus on the physicochemical compatibility and stability of all-in-one admixtures for neonatal use 10.1186/1475-2891-8-51 2009
Bioequivalence studies and sugar-based excipients effects on the properties of new generic ketoconazole tablets formulations and stability evaluation by using direct compression method 10.1080/10837450902832877 2009
Antiophidian sera sterelity control:Topics in perspective 10.1590/S1984-82502009000300004 2009
Development and Validation of a Discriminative Dissolution Test for Nimesulide Suspensions 10.1208/s12249-009-9320-4 2009
Development and validation of HPLC and UV spectrophotometric methods for the determination of lumiracoxib in tablets 2008
Desenvolvimento e validação de metodologia analítica para a determinação do teor de ácido glicólico na matéria-prima e em formulações dermocosméticas 10.1590/S1516-93322007000100005 2007
Ionic interventions that alter the association of troponin C C-domain with the thin filaments of vertebrate striated muscle 10.1016/j.bbagen.2005.09.014 2005
Determination of Minoxidil in Capsule By UV Spectrophotometric and Derivative UV Spectrophotometric Methods 2005
As bases estruturais e moleculares da contração muscular 2004
MODULATORS OF TROPONIN C (TNC) AFFINITY FOR THIN FILAMENTS (TF) IN SKINNED FIBERS OF SKELETAL AND CARDIAC MUSCLE 2001
Concerted action of the high affinity calcium binding sites in skeletal muscle Troponin C 10.1074/jbc.270.17.9770 1995
Eventos:

(0.00% eventos com DOI)

Titulo DOI Ano
In vitro antitumor activity of polymeric nanoparticles loaded with uncaria tomentosa extract 2015
Estudo de degradação forçada do roflumilaste 2015
Estudo Comparativo da liberação e permeação em cell de Franz utilizando membrana natural e sintetica 2015
Avaliação do perfil de liberação in vitro a partir de nanopartículas de PLGA contendo extrato de Uncaria Tomentosa 2014
Aprimoramento do porcentual de inclusão de nanopartículas de PCL contendo extrato de aloe vera 2014
Influence of the efavirenz micronization on tableting and dissolution 2014
Desenvolvimento e validação de teste de dissolução para comprimidos de liberação prolongada por BIO-DIS 2014
In Vitro Evaluation of Transdermal Rivastigmine Delivery System 2014
Formulation asn Characterisation of rivastigmine dry powers for pulmonary delivery 2014
Polymorphic transition of rivastigmina form II to I via ball milling 2014
Development of a Discriminative Intrinsic Dissolution Method for Efavirenz 2013
In vitro permeation and release studies for evaluation of transdermal patches 2013
Desenvolvimento de metodo por CLAE com detecção por aerosol carregado para topiramato e suas impurezas 2013
A validated HPLC method for quantification of betamethasone dipropionate and sodium phosphate in dissolution test of injectable suspensions 2012
Preparation and evaluation of nanostructured polymeric materials as vectorized systems of babassu oil 2011
Preparation and evaluation of new nanostructured systems for controlling oral pathologies caused by S.mutans and C. albicans 2011
Centro de Equivalência Farmacêutica (LabCQ) e a Farmacopeia Brasileira 2011
Centro de equivalencia farmaceutica da UFRJ REBLAS - LabCQ 2011
Desenvolvimento e avaliação de formulações nanoparticuladas contendo extratos com atividade antineoplasica 2011
Development and validation of analytical method by HPLC for simultaneous quantification of betamethasone dipropionate and betamethasone sodium phosphate in injectable suspension 2011
Preparação e Caracterização de Efavirenz Micronizado para Aumento da sua Dissolução 2011
Preparation and Characterization of Efavirenz Micronized Powder for Enhancement of Drug Solubility and Dissolution 2011
Development and validation of analytical method by HPLC for simultaneous quantification of betamethasone dipropionate and betamethasone sodium phosphate in injectable suspension 2011
Development of new nanoemulsions of dapsone for topic treatment of leprosy 2011
Poloxamer gels for topical application of lumiracoxib: influence of oleic acid on rheology and in vitro release studies 2009
Development of dissolution methodology for bromopride from controlled release pellets and correlation with physical caracterization 2009
Development of new microemulsions of dapsone for topic treatment of leprosy 2009
Development of new association of lidocaine hydrochloride and chlorexidine gluconatet in semisolid mucoadhesive formulation 2009
preparation of semisolid containing chlorexidhine in ciclodextrine 2009
Efeito do ácido oléico na permeação cutânea do antiinflamatório lumiracoxibe a partir de gel de poloxamer 2009
Géis de quitosano como sistemas de liberação para aplicação tópica do celecoxibe: influencia da azona nas propriedades reológicas e liberação in vitro 2009
Desenvolvimento e validação de metodologia analítica aplicada ao estudo de estabilidade e doseamento do celecoxibe matéria-prima 2009
Concentração de açúcares, pH, acidez titulável e viscosidade de antibacterianos líquidos pediátricos 2008
Development and validation of methodologies for the DMAE assay in dermocosmetc formulation in association of sunscreens 2007
The physicochemical study of preterm parenteral nutrition varying calcium and phosphorus relation 2007
Desenvolvimento, estudo de eficacia e segurança de um dermocosmetico contendo DMAE glicolato associado a filtros solares: ensaio de biometria cutânea e toxicidade dérmica 2007
Sugar content, titratable acidity and pH of liquid pediatric medicines 2007
Nutrição Parenteral para uso neonatal: o estudo de sua estabilidade físico-química 2007
Análise da Concentração de Açucares, pH, acidez titulável e viscosidade de medicamentos líquidos infantis 2007
Estudo da Uniformidade de Dose por Conteúdo na Impregnação de Glóbulos no. 07 2005
Desenvolvimento e Validação do Teor de Ácido Glicólico Associado à Hidroquinona em Formulação Cosmética 2005
Determination of minoxidil in capsule by UV spectrophotometric and derivative UV spectrophotometric methods 2005
Comparative study of methods to evaluate physicochemical stability of total nutrient admixtures (TNA) for parenteral use in neonates 2005
Comparative Study of Methods to Evaluate Physicochemical Stability of Total Nutrient Admixtures (TNA) for Parenteral Use in Neonates 2005
Avaliação da Estabilidade Física de Emulsões de Misturas Totais de Nutrientes para Uso Intravenoso em Pacientes Recém-Nascidos 2005
Estudo da Uniformidade de Dose por Conteúdo na Impregnação de Glóbulos no. 05 e 07 2005
Estudo de Estabilidade de Formulações Dermocosméticas contendo DMAE e Filtros Solares 2005
Avaliação da Estabilidade Físico-Química de Misturas 3 em 1 para Nutrição Parenteral Neonatal 2005
Influência da Relalção Cálcio:Fósforo na Estabilidade de Misturas 3 em 1 para Uso Neonatal 2005
Validação e desenvolvimento de método analítico para teor de ácido glicólico em formulações cosméticas 2004
Desenvolvimento e Validação do Teor de Ácido Glicólico Associado a Hidroquinona em Formulação Cosmética Formulação Cosmética 2004
Validação de Metodologia para Análise Quantitativa de Minoxidil por Espectrofotometria de Absorção no UV e Espectrofotometria Derivada 2004
Troponin C (TnC) redox state interferes with its binding to skeletal muscle thin filaments. 2003
Determinação do Teor de Ácido Glicólico em Formulações Cosméticas. 2003
Dissociation of troponin C from the thin filament of cardiac and skeletal skinned muscle fibers. 2002
Modulators of troponin C (TnC) affinity for thin filaments (TF) in skinned fibers of skeletal and cardiac muscle. 2001
Efeito cumulativo de condições que afetam a afinidade da TnC ao filamento fino de músculos esqueléticos e cardíacos 2001
Modulators of troponin C affinity for thin filaments in skinned fibers of skeletal and cardiac muscle 2001
Desenvolvimento de novas microemulsões de dapsona para o tratamento tópico da hanseníase 2001
Some conditions that affect dissociation of troponin C (TnC) from thin filaments (TF) in isolated fibers of rabbit. 2000
Condições que afetam a dissociação da troponina C (TnC) do filamento fino em fibras musculares "descascadas" isoladas de coelho. 2000
Dithiothreitol effects on the dissociation of troponin C (TnC) from thin filaments in skinned skletal muscle fibers. 1999
Low pH and low ionic strength favor association of troponin C with the thin filament in isolated skinned fibers. 1999
Experimental conditions that affect dissociation of troponin C (TnC) from thin filaments (TF) in isolated skinned fibers. 1998
Influência do ditiotreitol na associação da troponina C no filamento fino de músculo esquelético. 1998
Reconstitution of slow muscle skinned fibers with regulatory complex from fast muscle. 1995
Reconstituição de fibras descascadas de múscuo lento com o complexo regulatório de músculo rápido. 1995
The use of two specific troponin C (site I and II) mutants in an investigation of a possible interaction between regulatory sites in triggering muscle contraction. 1994
Publicações:
Minha Rede: